Therapy News and Research

RSS

Genetically engineering viruses to carry a suicide gene into ovarian cancer cells

Genetically engineering viruses to carry a suicide gene into ovarian cancer cells could become a potent way to tackle the disease, a leading Cancer Research UK scientist reveals at a conference in Glasgow today (Tuesday).

22 Jun 2004

New insights into a mysterious type of amnesia

Researchers have new insights into a mysterious type of amnesia, according to a study published in the June 22 issue of Neurology

21 Jun 2004

Virtual reality appears to dramatically change how the brain physically registers pain

The work, which used a specialized type of magnetic resonance imaging to track pain-related brain activity, showed drops of as much as 97 percent in such activity in some brain centers. The study marks the first time that scientists have documented a link between virtual reality and pain reduction in terms of an actual physiological response.

21 Jun 2004

Cognitive decline can occur before chemotherapy treatment

In a series of studies in breast cancer patients, researchers at The University of Texas M. D. Anderson Cancer Center have confirmed the presence of “chemobrain” after chemotherapy treatment – but they also discovered that a significant portion of patients have cognitive declines even before chemotherapy.

21 Jun 2004

Cost differences of methotrexate and cyclosporine to treat psoriasis neglible

The difference in cost associated with using two common treatments for psoriasis over the course of one year with treatment lasting 16 weeks are small.

21 Jun 2004

Aggressive treatment of brain blood clots can produce a good outcome for many stroke patients

In the study, published in a recent issue of the journal Neurosurgery, 50 percent of stroke patients had little or no neurological disability one to three months after clot-dissolving medication was delivered directly to the site of the blockages, compared to 39 percent of patients with similarly good outcomes documented in a large national trial of intravenous (IV) drug treatment for stroke.

21 Jun 2004

Cognitive Behaviour Therapy, a rapid, targeted, drug-free treatment option for depression

Initial results from a pilot study conducted by HMRI researchers based at the University of Newcastle suggest that there is an unmet treatment need for people suffering from depression and co-existing drug and alcohol problems.

21 Jun 2004

Chemobrain side effect in women may be overestimated

A new study says the incidence of "chemobrain," a widely reported side effect in women undergoing treatment for breast cancer, may be overestimated.

21 Jun 2004

Drug for multiple sclerosis prevented disease development when tested on animal models

Scientists from the Neurological Sciences Institute at Oregon Health & Science University have shown that an investigative drug for multiple sclerosis and related diseases prevented disease development when tested on animal models.

20 Jun 2004

$Hip fractures – less common but more numerous in an ageing nation$

Hip fractures – less common but more numerous in an ageing nation

Hip fracture rates are falling among older people for the first time but hospital admissions are rising despite the apparent success of prevention programs due to Australia’s aging population says research in the latest Medical Journal of Australia.

20 Jun 2004

Stimulation or drugs that target the pro-opiomelanocortin system will be effective in treating diabetes or obesity

There’s more than one way to slim a cat - at least that’s the hope of University of Florida obesity researchers, who believe pets and even people may someday benefit from gene therapy research aimed at breaking through the biochemical bottleneck that makes many middle-aged mammals gain weight.

17 Jun 2004

Statins could be effective in relieving symptoms of rheumatoid arthritis

Results of a UK study in this week's issue of THE LANCET suggest that the anti-inflammatory effect of statins (a class of cholesterol-lowering drugs) could be effective in relieving symptoms of rheumatoid arthritis.

17 Jun 2004

FDA panel to review results of Guidant's heart failure trial

Guidant Corporation has announced that the Circulatory System Devices Panel of the U.S. Food and Drug Administration (FDA) will review Guidant’s submission to expand user labeling, including indications, for its cardiac resynchronization therapy defibrillators

17 Jun 2004

Early patient response to Forteo in postmenopausal women with osteoporosis

Changes in markers of bone remodeling after one month of treatment with FORTEO® (teriparatide [rDNA origin] injection) may provide important early evidence of treatment response, according to new data presented today at the 86th Annual Meeting of The Endocrine Society (ENDO).

17 Jun 2004

Harmless virus known as GBV-C slows the progression of HIV

Iowa City Veterans Affairs (VA) Medical Center and University of Iowa (UI) researchers have unlocked part of the mystery of how a harmless virus known as GBV-C slows the progression of HIV and prolongs survival for many patients.

17 Jun 2004

Intrinsa patch increases sexual desire in menopausal women

Data released from a second, large-scale safety and efficacy study showed treatment with Intrinsa, an investigational female testosterone patch, significantly increased satisfying sexual activity and sexual desire in menopausal women

17 Jun 2004

More precise and less invasive procedure for prostate cancer detection

Work by a University of Queensland researcher will make the trip to the doctor for a prostate cancer check a lot more appealing for men.

17 Jun 2004

Australian researchers awarded funding for new HIV vaccines

Australian researchers at Monash University have been awarded $488,125 in development grants by the National Health and Medical Research Council (NHMRC) for projects exploring new vaccines for HIV, the development of medical diagnostic devices and the development of drugs to treat metastatic cancers.

17 Jun 2004

Australian researchers have identified the hormone DHEAS as a new marker of low libido in women under 45 years

Researchers at the Australian based Jean Hailes Foundation are addressing the complex role of hormones. Their aim is to understand what is normal and whether women may benefit from therapy. In one of the world’s most comprehensive studies into women’s health and hormones researchers looked at 1423 randomly selected women aged 18-75.

17 Jun 2004

Virtual reality helps people with stroke regain use of their upper limbs

Researchers from the University of Ulster and the Royal Hospitals have developed revolutionary techniques to help people with stroke regain use of their upper limbs, with the help of virtual reality.

17 Jun 2004

Therapy News and Research

Genetically engineering viruses to carry a suicide gene into ovarian cancer cells

New insights into a mysterious type of amnesia

Virtual reality appears to dramatically change how the brain physically registers pain

Cognitive decline can occur before chemotherapy treatment

Cost differences of methotrexate and cyclosporine to treat psoriasis neglible

Aggressive treatment of brain blood clots can produce a good outcome for many stroke patients

Cognitive Behaviour Therapy, a rapid, targeted, drug-free treatment option for depression

Chemobrain side effect in women may be overestimated

Drug for multiple sclerosis prevented disease development when tested on animal models

Hip fractures – less common but more numerous in an ageing nation

Stimulation or drugs that target the pro-opiomelanocortin system will be effective in treating diabetes or obesity

Statins could be effective in relieving symptoms of rheumatoid arthritis

FDA panel to review results of Guidant's heart failure trial

Early patient response to Forteo in postmenopausal women with osteoporosis

Harmless virus known as GBV-C slows the progression of HIV

Intrinsa patch increases sexual desire in menopausal women

More precise and less invasive procedure for prostate cancer detection

Australian researchers awarded funding for new HIV vaccines

Australian researchers have identified the hormone DHEAS as a new marker of low libido in women under 45 years

Virtual reality helps people with stroke regain use of their upper limbs

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News